NEW YORK, April 26, 2019 /PRNewswire/ -- Rowley Law
PLLC is investigating potential claims against Aratana
Therapeutics, Inc. (NASDAQ: PETX) and its board of directors for
breach of fiduciary duty concerning the proposed acquisition of the
company by Elanco Animal Health Incorporated (NYSE: ELAN).
Stockholders will receive 0.1481 shares of Elanco Animal Health
common stock and one contingent value right valued at $0.25 for each share of Aratana Therapeutics
stock that they hold. The transaction is valued at approximately
$245 million.
If you are a stockholder of Aratana Therapeutics, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/petx. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-aratana-therapeutics-inc-300839200.html
SOURCE Rowley Law PLLC